Related references
Note: Only part of the references are listed.Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
Diego O. Croci et al.
CELL (2014)
Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients
T. Kamigaito et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2014)
Emerging Principles for the Therapeutic Exploitation of Glycosylation
Martin Dalziel et al.
SCIENCE (2014)
Human fucosyltransferase 6 enables prostate cancer metastasis to bone
J. Li et al.
BRITISH JOURNAL OF CANCER (2013)
A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
Diego J. Laderach et al.
CANCER RESEARCH (2013)
Aberrant PSA glycosylation-a sweet predictor of prostate cancer
Sarah Gilgunn et al.
NATURE REVIEWS UROLOGY (2013)
VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1-and Galectin-3-Induced Angiogenesis
Nicky D'Haene et al.
PLOS ONE (2013)
Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis
Prasun Guha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence
Judith S. Knapp et al.
WORLD JOURNAL OF UROLOGY (2013)
The significance of galectin-3 as a new basal cell marker in prostate cancer
Y. Wang et al.
CELL DEATH & DISEASE (2013)
Delineating the galectin signature of the tumor microenvironment
Daniel Compagno et al.
ONCOIMMUNOLOGY (2013)
Human Prostate Cancer in a Clinically Relevant Xenograft Mouse Model: Identification of β(1,6)-Branched Oligosaccharides as a Marker of Tumor Progression
Tobias Lange et al.
CLINICAL CANCER RESEARCH (2012)
Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
Gabriel A. Rabinovich et al.
IMMUNITY (2012)
Tyrosine-phosphorylated Galectin-3 Protein Is Resistant to Prostate-specific Antigen (PSA) Cleavage
Vitaly Balan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Critical Role of O-Linked β-N-Acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and Metastasis
Thomas P. Lynch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
Diego O. Croci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Defining putative glycan cancer biomarkers by MS
Yehia Mechref et al.
BIOANALYSIS (2012)
Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-L-Leucine
Olga V. Glinskii et al.
NEOPLASIA (2012)
When Galectins Recognize Glycans: From Biochemistry to Physiology and Back Again
Santiago Di Lella et al.
BIOCHEMISTRY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Modulation of endothelial cell migration and angiogenesis: a novel function for the tandem-repeat lectin galectin-8
Victor M. Cardenas Delgado et al.
FASEB JOURNAL (2011)
Core fucosylation and α2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia
Radka Saldova et al.
GLYCOBIOLOGY (2011)
Galectin-3 Is a Substrate for Prostate Specific Antigen (PSA) in Human Seminal Plasma
Sarika Saraswati et al.
PROSTATE (2011)
Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
Victor L. Thijssen et al.
CANCER RESEARCH (2010)
Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion
Xiaoyan Yin et al.
CARBOHYDRATE RESEARCH (2010)
α1,2-Fucosylated and β-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer
Keiko Fukushima et al.
GLYCOBIOLOGY (2010)
Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer
Pratima Nangia-Makker et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis
Qicheng Zhao et al.
MOLECULAR CANCER (2010)
A systematic approach to protein glycosylation analysis: a path through the maze
Karina Marino et al.
NATURE CHEMICAL BIOLOGY (2010)
Regulation of Prostate Cancer Progression by Galectin-3
Yi Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions
Leah N. Cueni et al.
EXPERIMENTAL CELL RESEARCH (2009)
Core3 O-Glycan Synthase Suppresses Tumor Formation and Metastasis of Prostate Carcinoma PC3 and LNCaP Cells through Down-regulation of α2β1 Integrin Complex
Seung Ho Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Synthetic Galectin-3 Inhibitor Increases Metastatic Cancer Cell Sensitivity to Taxol-Induced Apoptosis In Vitro and In Vivo
Vladislav V. Glinsky et al.
NEOPLASIA (2009)
Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation
Gabriel A. Rabinovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin
Steven R. Barthel et al.
GLYCOBIOLOGY (2008)
Sialylation of β1 Integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis
Ya Zhuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Protein-glycan interactions in the control of innate and adaptive immune responses
Yvette van Kooyk et al.
NATURE IMMUNOLOGY (2008)
Frontiers in glycomics: Bioinformatics and biomarkers in disease - An NIH White Paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11-13,2006)
Nicolle H. Packer et al.
PROTEOMICS (2008)
Involvement of decreased galectin-3 expression in the pathogenesis and progression of prostate cancer
Axel S. Merseburger et al.
PROSTATE (2008)
SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas
Daniel Compagno et al.
PLOS ONE (2007)
Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia
Kim D. Johnson et al.
NEOPLASIA (2007)
O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1
Hector F. Valenzuela et al.
CANCER RESEARCH (2007)
Differential expression of galectins in normal, benign and malignant prostate epithelial cells: Silencing of galectin-3 expression in prostate cancer by its promoter methylation
Hafiz Ahmed et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The role of galectin-3 in cancer drug resistance
Tomoharu Fukumori et al.
DRUG RESISTANCE UPDATES (2007)
Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion
Lu-Gang Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11
Jamie Heimburg et al.
NEOPLASIA (2006)
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
Victor L. J. L. Thijssen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Glycans in cancer and inflammation. Potential for therapeutics and diagnostics
DH Dube et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
The current role of chemotherapy in metastatic hormone-refractory prostate cancer
DP Petrylak
UROLOGY (2005)
Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs
OV Glinskii et al.
NEOPLASIA (2005)
Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion
J Zou et al.
CARCINOGENESIS (2005)
Galectins as modulators of tumour progression
FT Liu et al.
NATURE REVIEWS CANCER (2005)
Dual activities of galectin-3 in human prostate cancer:: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3
S Califice et al.
ONCOGENE (2004)
Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy
C Ohyama et al.
GLYCOBIOLOGY (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins
R Peracaula et al.
GLYCOBIOLOGY (2003)
被撤回的出版物: Sustained induction of ERK, protein kinase B, and p70 S6 kinase regulates cell spreading and formation of F-actin microspikes upon ligation of integrins by galectin-8, a mammalian lectin (Retracted article. See vol. 293, pg. 7265, 2018)
Y Levy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: Clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine
SF Slovin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin
P Nangia-Makker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Overcoming multidrug resistance in taxane chemotherapy
R Geney et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2002)
Role of galectin-8 as a modulator of cell adhesion and cell growth
Y Zick et al.
GLYCOCONJUGATE JOURNAL (2002)
Galectin-8 functions as a matricellular modulator of cell adhesion
Y Levy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Galectin-3 induces endothetial cell morphogenesis and angiogenesis
P Nangia-Makker et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
